SEC FORM 3

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Ghazi Sassine

(Last)

(First)

(Middle)

690 EAST MIDDLEFIELD ROAD

(Street)

MOUNTAIN VIEW

94043

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
08/19/2020

3. Issuer Name and Ticker or Trading Symbol
SYNOPSYS INC [ SNPS ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Operating Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	31,552	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Non-Qualified Stock Option (right to buy)	08/23/2014⁽¹⁾	05/23/2021	Common Stock	3,590	$39.09	D
Non-Qualified Stock Option (right to buy)	08/22/2015⁽¹⁾	05/22/2022	Common Stock	8,948	$49.35	D
Non-Qualified Stock Option (right to buy)	08/20/2016⁽¹⁾	05/20/2023	Common Stock	3,209	$49.92	D
Non-Qualified Stock Option (right to buy)	09/17/2016⁽¹⁾	06/17/2023	Common Stock	1,442	$52.46	D
Non-Qualified Stock Option (right to buy)	03/15/2017⁽¹⁾	12/15/2023	Common Stock	58,272	$60.37	D
Non-Qualified Stock Option (right to buy)	12/12/2019⁽²⁾	12/12/2025	Common Stock	34,098	$89.76	D
Non-Qualified Stock Option (right to buy)	12/08/2018⁽²⁾	12/08/2024	Common Stock	30,881	$90.51	D
Non-Qualified Stock Option (right to buy)	12/12/2020⁽²⁾	12/12/2026	Common Stock	43,811	$135.88	D
Restricted Stock Units	⁽³⁾	12/08/2020	Common Stock	1,780	$0.0	D
Restricted Stock Units	⁽⁴⁾	12/08/2021	Common Stock	3,176	$0.0	D
Restricted Stock Units	⁽⁵⁾	12/08/2022	Common Stock	6,057	$0.0	D

Explanation of Responses:

1. Option vests in 16 equal quarterly installments beginning on the date shown, subject to continued service through each vesting date.

2. 25% of the grant becomes exercisable on the date shown with the remainder becoming exercisable in a series of 12 equal quarterly installments thereafter, subject to continued service through each vesting date.

3. The restricted stock units vested as to 25% of the total shares on 12/8/17 and the remaining 75% vest in three equal annual installments thereafter, subject to continued service through each vesting date.

4. The restricted stock units vested as to 25% of the total shares on 12/12/18 and the remaining 75% vest in three equal annual installments thereafter, subject to continued service through each vesting date.

5. The restricted stock units vested as to 25% of the total shares on 12/12/19 and the remaining 75% vest in three equal annual installments thereafter, subject to continued service through each vesting date.

	By: POA pursuant Christina Escalante-Dutra For: Sassine E. Ghazi	08/25/2020
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.